These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37187950)

  • 21. Diagnostic value of clinical parameters and parathyroid scintigraphy for asymptomatic primary hyperparathyroidism.
    Ning Y; Chen D; Huang Z; Lou C
    Hell J Nucl Med; 2020; 23(2):148-157. PubMed ID: 32716406
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Beheshti M; Hehenwarter L; Paymani Z; Rendl G; Imamovic L; Rettenbacher R; Tsybrovskyy O; Langsteger W; Pirich C
    Eur J Nucl Med Mol Imaging; 2018 Sep; 45(10):1762-1771. PubMed ID: 29516131
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Huang Z; Lou C
    J Int Med Res; 2019 Feb; 47(2):836-845. PubMed ID: 30556441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The diagnostic utility of dual phase Tc-99m sestamibi parathyroid imaging.
    Klieger P; O'Mara R
    Clin Nucl Med; 1998 Apr; 23(4):208-11. PubMed ID: 9554190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parathyroid dual tracer subtraction scintigraphy: small regions method for quantitative assessment of parathyroid adenoma uptake.
    Koljević Marković A; Janković MM; Marković I; Pupić G; Džodić R; Delaloye AB
    Ann Nucl Med; 2014 Oct; 28(8):736-45. PubMed ID: 24947176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parathyroid imaging with pertechnetate plus perchlorate/MIBI subtraction scintigraphy: a fast and effective technique.
    Rubello D; Saladini G; Casara D; Borsato N; Toniato A; Piotto A; Bernante P; Pelizzo MR
    Clin Nucl Med; 2000 Jul; 25(7):527-31. PubMed ID: 10885694
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Rep S; Hocevar M; Vaupotic J; Zdesar U; Zaletel K; Lezaic L
    J Radiol Prot; 2018 Mar; 38(1):343-356. PubMed ID: 29339573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual-tracer 99mTc-sestamibi/ 123I imaging in primary hyperparathyroidism.
    Tlili G; Mesguich C; Gaye D; Tabarin A; Haissaguerre M; Hindié E
    Q J Nucl Med Mol Imaging; 2023 Jun; 67(2):114-121. PubMed ID: 36748984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of SPECT/CT, SPECT, and planar imaging with single- and dual-phase (99m)Tc-sestamibi parathyroid scintigraphy.
    Lavely WC; Goetze S; Friedman KP; Leal JP; Zhang Z; Garret-Mayer E; Dackiw AP; Tufano RP; Zeiger MA; Ziessman HA
    J Nucl Med; 2007 Jul; 48(7):1084-9. PubMed ID: 17574983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is dual-phase SPECT/CT with 99mTc-sestamibi better than single-phase SPECT/CT for lesion localization in patients with hyperparathyroidism?
    Lee SH; Shin E; Ha S; Oh JS; Song DE; Ryu JS
    Medicine (Baltimore); 2020 May; 99(19):e19989. PubMed ID: 32384452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dual-isotope subtraction SPECT-CT in parathyroid localization.
    Woods AM; Bolster AA; Han S; Poon FW; Colville D; Shand J; Neilly JB
    Nucl Med Commun; 2017 Dec; 38(12):1047-1054. PubMed ID: 28984813
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Tunninen V; Varjo P; Kauppinen T; Holm A; Eskola H; Seppänen M
    Int J Mol Imaging; 2017; 2017():2712018. PubMed ID: 29181196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parathyroid imaging using simultaneous double-window recording of technetium-99m-sestamibi and iodine-123.
    Hindié E; Mellière D; Jeanguillaume C; Perlemuter L; Chéhadé F; Galle P
    J Nucl Med; 1998 Jun; 39(6):1100-5. PubMed ID: 9627353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parathyroid Imaging with Simultaneous Acquisition of 99mTc-Sestamibi and 123I: The Relative Merits of Pinhole Collimation and SPECT/CT.
    Bhatt PR; Klingensmith WC; Bagrosky BM; Walter JC; McFann KK; McIntyre RC; Raeburn CD; Koo PJ
    J Nucl Med Technol; 2015 Dec; 43(4):275-81. PubMed ID: 26584615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Evaluation of Corrective Reconstruction Method For Reduced Acquisition Time and Various Anatomies of Perfusion Defect Using Channelized Hotelling Observer for Myocardial Perfusion SPECT.
    Lee TS; Tsui BM
    IEEE Nucl Sci Symp Conf Rec (1997); 2010; 2010():3523-3526. PubMed ID: 26536462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of reconstruction algorithms on the accuracy of (99m)Tc sestamibi SPECT/CT parathyroid imaging.
    Nichols KJ; Tronco GG; Palestro CJ
    Am J Nucl Med Mol Imaging; 2015; 5(2):195-203. PubMed ID: 25973340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of ⁹⁹mTc-sestamibi SPECT/CT for minimally invasive parathyroidectomy: comparative study with ⁹⁹mTc-sestamibi scintigraphy, SPECT, US and CT.
    Kim YI; Jung YH; Hwang KT; Lee HY
    Ann Nucl Med; 2012 Dec; 26(10):804-10. PubMed ID: 22875576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sestamibi parathyroid imaging.
    McBiles M; Lambert AT; Cote MG; Kim SY
    Semin Nucl Med; 1995 Jul; 25(3):221-34. PubMed ID: 7570042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Parathyroid detection in secondary hyperparathyroidism with 123I/99mTc-sestamibi subtraction single photon emission computed tomography.
    Neumann DR; Esselstyn CB; Madera A; Wong CO; Lieber M
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3867-71. PubMed ID: 9814460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The value of 99mTc-sestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas or hyperplasia.
    Gayed IW; Kim EE; Broussard WF; Evans D; Lee J; Broemeling LD; Ochoa BB; Moxley DM; Erwin WD; Podoloff DA
    J Nucl Med; 2005 Feb; 46(2):248-52. PubMed ID: 15695783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.